GraniteShares Autocallable COIN ETF (ATC)
| Assets | $929.22K |
| Expense Ratio | 1.07% |
| PE Ratio | n/a |
| Forward PE | n/a |
| Shares Out | 40,001 |
| Dividend | $3.38 (15.64%) |
| Ex-Dividend Date | Oct 7, 2026 |
| Payout Frequency | Monthly |
| Payout Ratio | n/a |
| Volume | 128 |
| Open | 21.59 |
| Previous Close | 23.34 |
| Day's Range | 21.59 - 21.59 |
| 52-Week Low | 19.96 |
| 52-Week High | 25.36 |
| Beta | n/a |
| Holdings | 13 |
| Inception Date | May 12, 2026 |
About ATC
Fund Home PageThe GraniteShares Autocallable COIN ETF (ATC) is an exchange-traded fund that mostly invests in income alternatives. The fund is actively managed, investing in a laddered portfolio of single-stock autocallable options referencing the price of Coinbase Global, Inc. (NASDAQ: COIN) ATC was launched on May 12, 2026 and is issued by GraniteShares.
Top 10 Holdings
163.71% of assets| Name | Symbol | Weight |
|---|---|---|
| Cash & Cash Equivalents | n/a | 70.29% |
| Us Dollars | n/a | 36.94% |
| Coin Trs 50% Eki Nomura | n/a | 20.71% |
| Coin Trs 55% Eki Nomura | n/a | 20.34% |
| Coin Trs 60% Eki Nomura | n/a | 20.09% |
| Coin Trs 65% Eki Nomura | n/a | 19.61% |
| Coin Trs 70% Eki Nomura | n/a | 19.13% |
| Cash | n/a | -0.93% |
| Coin Trs 50% Eki Nomura | n/a | -21.24% |
| Coin Trs 55% Eki Nomura | n/a | -21.24% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Oct 7, 2026 | $0.74243 | Oct 9, 2026 |
| Sep 9, 2026 | $0.74901 | Sep 11, 2026 |
| Aug 12, 2026 | $0.57205 | Aug 14, 2026 |
| Jul 1, 2026 | $0.5814 | Jul 6, 2026 |
| Jun 3, 2026 | $0.73256 | Jun 5, 2026 |
Performance
News
GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA
New York, July 02, 2026 (GLOBE NEWSWIRE) -- GraniteShares today announced the monthly distributions for its GraniteShares Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA as shown in the t...
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinicall...
Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026
Schlieren / Zurich, Switzerland, 18 June, 2026 – Memo Therapeutics AG (“MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and ca...
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced its robust scientific presence at the upcoming American Transplant...
World Wide Technology Launches ‘Defending at the Speed of AI' Initiative with Horizon3.ai, Empirical Security, Infoblox, and Cognition
ST. LOUIS--(BUSINESS WIRE)--World Wide Technology (WWT), a global technology solutions provider, today announced the launch of “Defending at the Speed of AI,” a global cybersecurity initiative WWT dev...